标题
Integrin-mediated cancer progression as a specific target in clinical therapy
作者
关键词
-
出版物
BIOMEDICINE & PHARMACOTHERAPY
Volume 155, Issue -, Pages 113745
出版商
Elsevier BV
发表日期
2022-09-28
DOI
10.1016/j.biopha.2022.113745
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Integrin alpha5 in human breast cancer is a mediator of bone metastasis and a therapeutic target for the treatment of osteolytic lesions
- (2021) Francesco Pantano et al. ONCOGENE
- Cyclic RGD Pentapeptide Cilengitide Enhances Efficacy of Gefitinib on TGF-β1-Induced Epithelial-to-Mesenchymal Transition and Invasion in Human Non-Small Cell Lung Cancer Cells
- (2021) Jisu Jeong et al. Frontiers in Pharmacology
- CD151 drives cancer progression depending on integrin α3β1 through EGFR signaling in non-small cell lung cancer
- (2021) Jianjie Zhu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Integrin β7 Inhibits Colorectal Cancer Pathogenesis via Maintaining Antitumor Immunity
- (2021) Youhua Zhang et al. Cancer Immunology Research
- Inhibition of matrix stiffness relating integrin β1 signaling pathway inhibits tumor growth in vitro and in hepatocellular cancer xenografts
- (2021) Changsong Wang et al. BMC CANCER
- Inhibition of integrin subunit alpha 11 restrains gastric cancer progression through phosphatidylinositol 3-kinase/Akt pathway
- (2021) Haijun Zhang et al. Bioengineered
- TAZ target gene ITGAV regulates invasion and feeds back positively on YAP and TAZ in liver cancer cells
- (2020) Sofia M.E. Weiler et al. CANCER LETTERS
- The exosomal integrin α5β1/AEP complex derived from epithelial ovarian cancer cells promotes peritoneal metastasis through regulating mesothelial cell proliferation and migration
- (2020) Xiaoduan Li et al. CELLULAR ONCOLOGY
- Secreted Pyruvate Kinase M2 Promotes Lung Cancer Metastasis through Activating the Integrin Beta1/FAK Signaling Pathway
- (2020) Caihong Wang et al. Cell Reports
- Extracellular Matrix Derived from High Metastatic Human Breast Cancer Triggers Epithelial-Mesenchymal Transition in Epithelial Breast Cancer Cells through αvβ3 Integrin
- (2020) Renata Machado Brandão-Costa et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Fibrinogen Alpha Chain Knockout Promotes Tumor Growth and Metastasis through Integrin-AKT Signaling Pathway in Lung Cancer
- (2020) Meng Wang et al. MOLECULAR CANCER RESEARCH
- Maspin suppresses cell invasion and migration in gastric cancer through inhibiting EMT and angiogenesis via ITGB1/FAK pathway
- (2020) Ning Wang et al. Human Cell
- THBS4 promotes HCC progression by regulating ITGB1 via FAK/PI3K/AKT pathway
- (2020) Dan Guo et al. FASEB JOURNAL
- Roles of Membrane Domains in Integrin-Mediated Cell Adhesion
- (2020) Daniel Lietha et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Periostin regulates autophagy through integrin α5β1 or α6β4 and an AKT‐dependent pathway in colorectal cancer cell migration
- (2020) Suyanee Thongchot et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- A comparative assessment of the effects of integrin inhibitor cilengitide on primary culture of head and neck squamous cell carcinoma (HNSCC) and HNSCC cell lines
- (2019) L. Zhang et al. Clinical & Translational Oncology
- Platelet integrin αIIbβ3: signal transduction, regulation, and its therapeutic targeting
- (2019) Jiansong Huang et al. Journal of Hematology & Oncology
- NPTX1 promotes metastasis via integrin/FAK signaling in gastric cancer
- (2019) Hongfei Yan et al. Cancer Management and Research
- Collagen facilitates the colorectal cancer stemness and metastasis through an integrin/PI3K/AKT/Snail signaling pathway
- (2019) Xiangbin Wu et al. BIOMEDICINE & PHARMACOTHERAPY
- Platelets promote breast cancer cell MCF-7 metastasis by direct interaction: surface integrin α2β1-contacting-mediated activation of Wnt-β-catenin pathway
- (2019) Xiao-xiao Zuo et al. Cell Communication and Signaling
- Interleukin-8 promotes integrin β3 upregulation and cell invasion through PI3K/Akt pathway in hepatocellular carcinoma
- (2019) Fengkai Sun et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Interaction between laminin-5γ2 and integrin β1 promotes the tumor budding of colorectal cancer via the activation of Yes-associated proteins
- (2019) Bijiao Zhou et al. ONCOGENE
- Integrin β4–Targeted Cancer Immunotherapies Inhibit Tumor Growth and Decrease Metastasis
- (2019) Shasha Ruan et al. CANCER RESEARCH
- Integrin α11 in non–small cell lung cancer is associated with tumor progression and postoperative recurrence
- (2019) Takahiro Ando et al. CANCER SCIENCE
- Integrin alpha 7 correlates with poor clinical outcomes, and it regulates cell proliferation, apoptosis and stemness via PTK2-PI3K-Akt signaling pathway in hepatocellular carcinoma
- (2019) Jun-Chen Ge et al. CELLULAR SIGNALLING
- Dietary delphinidin inhibits human colorectal cancer metastasis associating with upregulation of miR-204-3p and suppression of the integrin/FAK axis
- (2019) Chi-Chou Huang et al. Scientific Reports
- Integrins in wound healing, fibrosis and tumor stroma: High potential targets for therapeutics and drug delivery
- (2018) Jonas Schnittert et al. ADVANCED DRUG DELIVERY REVIEWS
- Blockade of ITGA2 Induces Apoptosis and Inhibits Cell Migration in Gastric Cancer
- (2018) Yu-Chang Chuang et al. BIOLOGICAL PROCEDURES ONLINE
- Integrin diversity brings specificity in mechanotransduction
- (2018) Shailaja Seetharaman et al. BIOLOGY OF THE CELL
- SPON2 Promotes M1-like Macrophage Recruitment and Inhibits Hepatocellular Carcinoma Metastasis by Distinct Integrin–Rho GTPase–Hippo Pathways
- (2018) Yan-Li Zhang et al. CANCER RESEARCH
- ADAM17 promotes cell migration and invasion through the integrin β1 pathway in hepatocellular carcinoma
- (2018) Yong Li et al. EXPERIMENTAL CELL RESEARCH
- The Novel Oncolytic Adenoviral Mutant Ad5-3Δ-A20T Retargeted to αvβ6 Integrins Efficiently Eliminates Pancreatic Cancer Cells
- (2018) Y. K. Stella Man et al. MOLECULAR CANCER THERAPEUTICS
- Prostate cancer sheds the αvβ3 integrin in vivo through exosomes
- (2018) Shiv Ram Krishn et al. MATRIX BIOLOGY
- Integrin αvβ6 plays a bi-directional regulation role between colon cancer cells and cancer-associated fibroblasts
- (2018) Cheng Peng et al. BIOSCIENCE REPORTS
- Cancer-associated fibroblast-derived Lumican promotes gastric cancer progression via the integrin β1-FAK signaling pathway
- (2017) Xiaofeng Wang et al. INTERNATIONAL JOURNAL OF CANCER
- Integrins and Cell Metabolism: An Intimate Relationship Impacting Cancer
- (2017) Rehman Ata et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Tumor-penetrating peptide enhances transcytosis of silicasome-based chemotherapy for pancreatic cancer
- (2017) Xiangsheng Liu et al. JOURNAL OF CLINICAL INVESTIGATION
- Integrin-targeted cancer immunotherapy elicits protective adaptive immune responses
- (2017) Byron H. Kwan et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The activated conformation of integrin β7 is a novel multiple myeloma–specific target for CAR T cell therapy
- (2017) Naoki Hosen et al. NATURE MEDICINE
- The Therapeutic Antibody LM609 Selectively Inhibits Ligand Binding to Human α V β 3 Integrin via Steric Hindrance
- (2017) Andrew J. Borst et al. STRUCTURE
- Potential of Integrin Inhibitors for Treating Ovarian Cancer: A Literature Review
- (2017) et al. Cancers
- The complexity of integrins in cancer and new scopes for therapeutic targeting
- (2016) Hellyeh Hamidi et al. BRITISH JOURNAL OF CANCER
- A phase I, dose escalation, pharmacodynamic, pharmacokinetic, and food-effect study of α2 integrin inhibitor E7820 in patients with advanced solid tumors
- (2016) B. Milojkovic Kerklaan et al. INVESTIGATIONAL NEW DRUGS
- A dose escalating phase I study of GLPG0187, a broad spectrum integrin receptor antagonist, in adult patients with progressive high-grade glioma and other advanced solid malignancies
- (2016) Geert A. Cirkel et al. INVESTIGATIONAL NEW DRUGS
- Exosome-mediated Transfer of v 3 Integrin from Tumorigenic to Nontumorigenic Cells Promotes a Migratory Phenotype
- (2016) A. Singh et al. MOLECULAR CANCER RESEARCH
- The effect of antagonizing RGD-binding integrin activity in papillary thyroid cancer cell lines
- (2016) Weiwei Cheng et al. OncoTargets and Therapy
- Integrin α7 is a functional cancer stem cell surface marker in oesophageal squamous cell carcinoma
- (2016) Xiao-Yan Ming et al. Nature Communications
- Integrin α6 promotes esophageal cancer metastasis and is targeted by miR-92b
- (2016) Gang Ma et al. Oncotarget
- Research advances on structure and biological functions of integrins
- (2016) Li Pan et al. SpringerPlus
- Cilengitide combined with cetuximab and platinum-based chemotherapy as first-line treatment in advanced non-small-cell lung cancer (NSCLC) patients: results of an open-label, randomized, controlled phase II study (CERTO)
- (2015) J. Vansteenkiste et al. ANNALS OF ONCOLOGY
- Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abrogates metastasis and enhances drug efficacy
- (2015) Bryan W Miller et al. EMBO Molecular Medicine
- The αvβ6Integrin Is Transferred Intercellularly via Exosomes
- (2015) Carmine Fedele et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Colorectal Cancer Metastases Settle in the Hepatic Microenvironment Through α5β1 Integrin
- (2015) Chiara Pelillo et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Tumour exosome integrins determine organotropic metastasis
- (2015) Ayuko Hoshino et al. NATURE
- Integrin α11β1 regulates cancer stromal stiffness and promotes tumorigenicity and metastasis in non-small cell lung cancer
- (2015) R Navab et al. ONCOGENE
- Integrin αvβ6 sustains and promotes tumor invasive growth in colon cancer progression
- (2015) Guang-Yun Yang WORLD JOURNAL OF GASTROENTEROLOGY
- Silencing profilin-1 inhibits gastric cancer progressionviaintegrin β1/focal adhesion kinase pathway modulation
- (2015) Ya-Jun Cheng WORLD JOURNAL OF GASTROENTEROLOGY
- S100P interacts with integrin α7 and increases cancer cell migration and invasion in lung cancer
- (2015) Ya-Ling Hsu et al. Oncotarget
- Integrin activation
- (2015) Mark H. Ginsberg BMB Reports
- Tumor-Selective Response to Antibody-Mediated Targeting of αvβ3 Integrin in Ovarian Cancer
- (2015) Charles N. Landen et al. NEOPLASIA
- Targeting of αv-Integrins in Stem/Progenitor Cells and Supportive Microenvironment Impairs Bone Metastasis in Human Prostate Cancer
- (2015) Geertje van der Horst et al. NEOPLASIA
- Cisplatin, 5-fluorouracil, and cetuximab (PFE) with or without cilengitide in recurrent/metastatic squamous cell carcinoma of the head and neck: results of the randomized phase I/II ADVANTAGE trial (phase II part)
- (2014) J. B. Vermorken et al. ANNALS OF ONCOLOGY
- Enhanced anti-angiogenic effect of E7820 in combination with erlotinib in epidermal growth factor receptor-tyrosine kinase inhibitor-resistant non-small-cell lung cancer xenograft models
- (2014) Ken Ito et al. CANCER SCIENCE
- Cilengitide, a small molecule antagonist, targeted to integrin αν inhibits proliferation and induces apoptosis of laryngeal cancer cells in vitro
- (2014) Jing Ting Wang et al. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
- Metastatic signature in lung cancer is associated with sensitivity to anti-integrin αVmonoclonal antibody intetumumab
- (2014) Huiqing Liu et al. GENES CHROMOSOMES & CANCER
- Atomic Basis for the Species-specific Inhibition of αV Integrins by Monoclonal Antibody 17E6 Is Revealed by the Crystal Structure of αVβ3 Ectodomain-17E6 Fab Complex
- (2014) Bhuvaneshwari Mahalingam et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial
- (2014) Roger Stupp et al. LANCET ONCOLOGY
- Integrin αvβ3 is required for cathepsin B-induced hepatocellular carcinoma progression
- (2014) ZONG-ZHEN XU et al. Molecular Medicine Reports
- β1 integrin modulates tumor growth and apoptosis of human colorectal cancer
- (2014) JIA SONG et al. ONCOLOGY REPORTS
- 1 Integrin Inhibition Elicits a Prometastatic Switch Through the TGF -miR-200-ZEB Network in E-Cadherin-Positive Triple-Negative Breast Cancer
- (2014) H. H. Truong et al. Science Signaling
- β1 integrin mediates colorectal cancer cell proliferation and migration through regulation of the Hedgehog pathway
- (2014) Jia Song et al. TUMOR BIOLOGY
- Investigational Analysis Reveals a Potential Role for Neutrophils in Giant-Cell Arteritis Disease Progression
- (2013) Suchita Nadkarni et al. CIRCULATION RESEARCH
- Integrin alpha 6: A novel therapeutic target in esophageal squamous cell carcinoma
- (2013) JUNHYE KWON et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- The Differentiation of Pancreatic Tumor-Initiating Cells by Vitronectin Can Be Blocked by Cilengitide
- (2013) Stephanie M. Cabarcas et al. PANCREAS
- Integrins and metastasis
- (2013) Kirat Kumar Ganguly et al. Cell Adhesion & Migration
- A randomized, double-blind, multicenter, phase 2 study of a human monoclonal antibody to human αν integrins (intetumumab) in combination with docetaxel and prednisone for the first-line treatment of patients with metastatic castration-resistant prostate cancer
- (2012) A. Heidenreich et al. ANNALS OF ONCOLOGY
- Dual inhibition of αV integrins and Src kinase activity as a combination therapy strategy for colorectal cancer
- (2012) Jingquan Jia et al. ANTI-CANCER DRUGS
- A safety run-in and randomized phase 2 study of cilengitide combined with chemoradiation for newly diagnosed glioblastoma (NABTT 0306)
- (2012) L. Burt Nabors et al. CANCER
- Integrin β5 contributes to the tumorigenic potential of breast cancer cells through the Src-FAK and MEK-ERK signaling pathways
- (2012) A Bianchi-Smiraglia et al. ONCOGENE
- Knockdown of integrin α3β1 expression induces proliferation and migration of non-small cell lung cancer cells
- (2012) HYUN JAE YOON et al. ONCOLOGY REPORTS
- Integrin Targeted Therapeutics
- (2012) Melissa Millard et al. Theranostics
- Targeting tumor cell motility to prevent metastasis
- (2011) Trenis D. Palmer et al. ADVANCED DRUG DELIVERY REVIEWS
- A randomised, phase II study of intetumumab, an anti-αv-integrin mAb, alone and with dacarbazine in stage IV melanoma
- (2011) S O'Day et al. BRITISH JOURNAL OF CANCER
- Phase I Study of E7820, an Oral Inhibitor of Integrin -2 Expression with Antiangiogenic Properties, in Patients with Advanced Malignancies
- (2011) M. Mita et al. CLINICAL CANCER RESEARCH
- 1-Integrin: A Potential Therapeutic Target in the Battle against Cancer Recurrence
- (2011) D. Barkan et al. CLINICAL CANCER RESEARCH
- Volociximab in cancer
- (2011) Salah Almokadem et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Integrin α3β1 as a breast cancer target
- (2011) Sita Subbaram et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Targeting integrins in hepatocellular carcinoma
- (2011) Yanhua Wu et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- A phase II, single-arm study of the anti-α5β1 integrin antibody volociximab as monotherapy in patients with platinum-resistant advanced epithelial ovarian or primary peritoneal cancer
- (2011) Katherine M. Bell-McGuinn et al. GYNECOLOGIC ONCOLOGY
- Expression of αV-Integrins in Uterine Serous Papillary Carcinomas; Implications for Targeted Therapy With Intetumumab (CNTO 95), a Fully Human Antagonist Anti-αV-Integrin Antibody
- (2011) Marta Bellone et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Integrin 5 1 facilitates cancer cell invasion through enhanced contractile forces
- (2011) C. T. Mierke et al. JOURNAL OF CELL SCIENCE
- Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases
- (2011) Peter Carmeliet et al. NATURE REVIEWS DRUG DISCOVERY
- Integrin Structure, Activation, and Interactions
- (2011) I. D. Campbell et al. Cold Spring Harbor Perspectives in Biology
- A randomized phase 2 study of etaracizumab, a monoclonal antibody against integrin αvβ3, ± dacarbazine in patients with stage IV metastatic melanoma
- (2010) Peter Hersey et al. CANCER
- Phase II study of Cilengitide (EMD 121974, NSC 707544) in patients with non-metastatic castration resistant prostate cancer, NCI-6735. A study by the DOD/PCF prostate cancer clinical trials consortium
- (2010) Ajjai Alva et al. INVESTIGATIONAL NEW DRUGS
- The α2β1 integrin is a metastasis suppressor in mouse models and human cancer
- (2010) Norma E. Ramirez et al. JOURNAL OF CLINICAL INVESTIGATION
- Integrin α6Bβ4 inhibits colon cancer cell proliferation and c-Myc activity
- (2009) Anders Bondo Dydensborg et al. BMC CANCER
- Mechanism-based receptor-binding model to describe the pharmacokinetic and pharmacodynamic of an anti-α5β1 integrin monoclonal antibody (volociximab) in cancer patients
- (2009) Chee M. Ng et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Integrins
- (2008) Rita Silva et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- CYR61 and V 5 Integrin Cooperate to Promote Invasion and Metastasis of Tumors Growing in Preirradiated Stroma
- (2008) Y. Monnier et al. CANCER RESEARCH
- Volociximab, a Chimeric Monoclonal Antibody that Specifically Binds 5 1 Integrin: A Phase I, Pharmacokinetic, and Biological Correlative Study
- (2008) A. D. Ricart et al. CLINICAL CANCER RESEARCH
- Transforming growth factor-β1 increases cell migration and β1 integrin up-regulation in human lung cancer cells
- (2008) Yi-Chin Fong et al. LUNG CANCER
- Anti-integrin monoclonal antibody CNTO 95 enhances the therapeutic efficacy of fractionated radiation therapy in vivo
- (2008) Shoucheng Ning et al. MOLECULAR CANCER THERAPEUTICS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started